Buscar en
Nursing
Toda la web
Inicio Nursing Enfermedades mitocondriales: problemas en la planta de producción de energía
Información de la revista
Vol. 30. Núm. 8.
Páginas 21-26 (Octubre 2012)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 30. Núm. 8.
Páginas 21-26 (Octubre 2012)
Acceso a texto completo
Enfermedades mitocondriales: problemas en la planta de producción de energía
Visitas
1872
Gail Reiner
Es profesional de enfermería de nivel III y coordinadora de investigación en neurociencias
Jan Panyard-Davis
Es coordinador de investigación clínica, ambos en el Mitochondrial and Metabolic Disease Center at the University of California-San Diego, en San Diego (California)
Este artículo ha recibido
Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
R.H. Haas.
Autism and mitochondrial disease.
Dev Disabil Res Rev, 16 (2010), pp. 144-153
[2.]
Genge A, Massie R. Mitochondrial myopathies: clinical features and diagnosis, 2012. http://www.uptodate.com/contents/mitochondrial-myopathies-clinical-features-and-diagnosis.
[3.]
A.M. Schaefer, R. McFarland, E.L. Blakely, et al.
Prevalence of mitochondrial DNAdisease in adults.
Ann Neurol, 63 (2008), pp. 35-39
[4.]
H.R. Elliott, D.C. Samuels, J.A. Eden, C.L. Relton, P.F. Chinnery.
Pathogenic mitochondrial DNA mutations are common in the general population.
Am J Hum Genet, 83 (2008), pp. 254-260
[5.]
Genetics Home Reference. What is mitochondrial DNA? 2012. http://ghr.nlm.nih.gov/handbook/basics/mtdna.
[6.]
J. Finsterer, H.F. Harbo, J. Baets, et al.
EFNS guidelines on the molecular diagnosis of mitochondrial disorders.
Eur J Neurol, 16 (2009), pp. 1255-1264
[7.]
Genge A, Massie R. Mitochondrial structure, function, and genetics. UpToDate. 2012. http://www.uptodate.com/contents/mitochondrial-structure-function-and-genetics.
[8.]
R.H. Haas, S. Parikh, Mitochondrial Medicine Society's Committee on Diagnosis, et al.
The in-depth evaluation of suspected mitochondrial disease.
Mol Genet Metab, 94 (2008), pp. 16-37
[9.]
LHON: Leber's hereditary optic neuropathy. LHON101. http://www.lhon.org/lhon/LHON_101.html.
[10.]
National Institute of Neurological Disorders and Stroke. NINDS Leigh's disease information page. 2011. http://www.ninds.nih.gov/disorders/leighsdisease/leighsdisease.htm.
[11.]
B. Cohen, R.K. Naviaux.
The clinical diagnosis of POLG disease and other mitochondrial DNA depletion disorders.
Methods, 51 (2010), pp. 364-373
[12.]
National Institute of Neurological Disorders and Stroke. NINDS Alpers’ disease information page. 2011. http://www.ninds.nih.gov/disorders/alpersdisease/alpersdisease.htm.
[13.]
R.H. Haas, S. Parikh, M.J. Falk, et al.
Mitochondrial disease: a practical approach for primary care physicians.
Pediatrics, 120 (2007), pp. 1326-1330
[14.]
S. Mohammed, W. Bahitham, A. Chan, B. Chiu, F. Bamforth, C. Sergi.
Mitochondrial DNA related cardiomyopathies.
Front Biosci (Elite Ed), 4 (2012), pp. 1706-1710
[15.]
R.P. Saneto, S.D. Friedman, D.W. Shaw.
Neuroimaging of mitochondrial disease.
Mitochondrion, 8 (2008), pp. 396-413
[16.]
R.G. Boles, E.E. Baldwin, T.R. Prezant.
Combined cyclic vomiting and Kearns-Sayre syndromes.
Pediatr Neurol, 36 (2007), pp. 135-136
[17.]
D.C. Wallace.
Mitochondrial diseases in man and mouse.
Science, 283 (1999), pp. 1482-1490
[18.]
S. Parikh, R. Saneto, M.J. Falk, I. Anselm, B.H. Cohen, R. Haas.
Amodern approach to the treatment of mitochondrial disease.
Curr Treat Options Neurol, 11 (2009), pp. 414-430
[19.]
L. Palmieri, A.M. Persico.
Mitochondrial dysfunction in autism spectrum disorders: cause or effect?.
Biochim Biophys Acta, 1797 (2010), pp. 1130-1140
[20.]
M. Tarnopolsky.
Exercise testing in metabolic myopathies.
Phys Med Rehabil Clin NAm, 23 (2012), pp. 173-186
[21.]
J.J. Driessen.
Neuromuscular and mitochondrial disorders: what is relevant to the anaesthesiologist?.
Curr Opin Anaesthesiol, 21 (2008), pp. 350-355
[22.]
R.H. Haas.
The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease.
Mitochondrion, 7 (2007), pp. S136-S145
[23.]
D.S. Kerr.
Treatment of mitochondrial electron transport chain disorders: a review of clinical trials over the past decade.
Mol Genet Metab, 99 (2010), pp. 246-255
[24.]
Genge A, Massie R. Mitochondrial myopathies: treatment. UpToDate. 2012. http://www.uptodate.com/contents/mitochondrial-myopathies-treatment.
[25.]
A.A. Sadun, F. Chicanic, F.N. Ross-Cisneros, et al.
Effect of EPI-743 on the clinical course of the mitochondrial disease Leber hereditary optic neuropathy.
Arch Neurol, 69 (2012), pp. 331-338
[26.]
G.M. Enns, S.L. Kinsman, S.L. Perlman, et al.
Initial experience in the treatment of inherited mitochondrial disease with EPI-743.
Mol Genet Metab, 105 (2012), pp. 91-102
[27.]
W.D. Shrader, A. Amagata, A. Barnes, et al.
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
Bioorg Med Chem Lett, 21 (2011), pp. 3693-3698
[28.]
E.M. Cusimano, A.R. Knight, J.G. Slusser, R.L. Clancy, J.D. Pierce, Mitochondria:.
the hemi of the cell.
Adv Emerg Nurs J, 31 (2009), pp. 54-62
Copyright © 2012. Lippincott Williams & Wilkins
Opciones de artículo
Herramientas
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos